Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for Muscle Spasms in Cirrhosis
NCT02298868Phase 2Completed
- Sponsor
- University of Virginia
- Start
- Oct 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of baclofen in muscle cramps, sponsored by University of Virginia. Primary endpoints: Number of Participants With Adverse Events as a Measure of Safety and Tolerability (Headache) at 4 weeks, Number of Participants With Adverse Events as a Measure of Safety and Tolerability (Nausea) at 4 weeks and 3 more. Started Oct 2012; status: completed.
02
Drugs
baclofen
03
Conditions
muscle cramps
Beyond the preview
Go deeper on NCT02298868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298868.